ストックスクリーナーアプリを入手
17.30
1.23%
0.21
Eton Pharmaceuticals Inc (ETON) 最新ニュース
Eton Pharmaceuticals to host 1x1 meetings at 2025 Wells Fargo Healthcare Conference. - AInvest
Eton Pharmaceuticals: A Rare Disease Innovator with Strategic Momentum and Investor Appeal - AInvest
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference - GlobeNewswire
Rare Disease Drug Developer Eton Pharmaceuticals to Meet Investors at Wells Fargo Healthcare Conference - Stock Titan
What institutional flow reveals about Eton Pharmaceuticals Inc.Portfolio Return Summary & Weekly High Return Stock Opportunities - Newser
Why Eton Pharmaceuticals Inc. is moving todayJuly 2025 Earnings & Smart Money Movement Alerts - Newser
Can Eton Pharmaceuticals Inc. recover in the next quarter2025 Winners & Losers & High Accuracy Investment Entry Signals - Newser
Smart tools for monitoring Eton Pharmaceuticals Inc.’s price actionVolume Spike & Proven Capital Preservation Methods - Newser
Live market analysis of Eton Pharmaceuticals Inc.July 2025 Institutional & Expert Approved Trade Ideas - Newser
Is Eton Pharmaceuticals Inc. trending in predictive chart modelsWeekly Profit Summary & Long Hold Capital Preservation Tips - Newser
Building trade automation scripts for Eton Pharmaceuticals Inc.Breakout Watch & Capital Efficient Trade Techniques - Newser
Chart overlay techniques for tracking Eton Pharmaceuticals Inc.2025 Buyback Activity & Verified Short-Term Trading Plans - Newser
Can technical indicators confirm Eton Pharmaceuticals Inc.’s reversalSell Signal & Growth Focused Entry Reports - Newser
Order flow analysis tools used on Eton Pharmaceuticals Inc.IPO Watch & Weekly Top Stock Performers List - Newser
Is now a turning point for Eton Pharmaceuticals Inc.2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Will Eton Pharmaceuticals Inc. Bounce From 52 Week LowWeekly Profit Summary & Growth Focused Entry Point Reports - newsimpact.co.kr
Eton Pharma Accuses Supplement Maker of Trademark Infringement - Bloomberg Law News
Quantitative breakdown of Eton Pharmaceuticals Inc. recent moveWeekly Profit Report & Reliable Volume Spike Trade Alerts - Newser
What data driven models say about Eton Pharmaceuticals Inc.’s futureWeekly Profit Report & AI Forecast Swing Trade Picks - Newser
Is Eton Pharmaceuticals Inc. stock entering bullish territoryGap Down & Daily Risk Controlled Trade Plans - Newser
How high can Eton Pharmaceuticals Inc. stock goJuly 2025 Decliners & Community Consensus Picks - Newser
What does recent volatility data suggest for Eton Pharmaceuticals Inc.2025 Bull vs Bear & High Accuracy Trade Signal Alerts - Newser
Detecting support and resistance levels for Eton Pharmaceuticals Inc.Market Growth Report & High Conviction Investment Ideas - Newser
Signal strength of Eton Pharmaceuticals Inc. stock in tech scannersWeekly Trade Analysis & Technical Buy Zone Confirmations - Newser
Eton Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingEarnings Performance Report & Daily Oversold Stock Bounce Ideas - Newser
Visualizing Eton Pharmaceuticals Inc. stock with heatmapsJuly 2025 Chart Watch & Daily Market Momentum Tracking - Newser
Published on: 2025-08-15 17:26:08 - Newser
What makes Eton Pharmaceuticals Inc. stock price move sharply2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
How Eton Pharmaceuticals Inc. stock reacts to Fed policy changesJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Is Eton Pharmaceuticals Inc. forming a bullish divergenceJuly 2025 Retail & Low Risk High Reward Trade Ideas - 선데이타임즈
Identifying reversal signals in Eton Pharmaceuticals Inc.2025 Valuation Update & High Accuracy Trade Alerts - Newser
XTX Topco Ltd Sells 2,858 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Published on: 2025-08-13 17:16:40 - 선데이타임즈
How to interpret RSI for Eton Pharmaceuticals Inc. stock [Gap Up]Free Low Drawdown Trading Techniques - Newser
Eton Pharmaceuticals Reports Strong Q2 Growth Amid Challenges - TipRanks
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2025 Earnings Call Transcript - Insider Monkey
With 43% Ownership in Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Institutional Investors Have a Lot Riding on the Business - 富途牛牛
Loss-Making Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Set To Breakeven - simplywall.st
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates - MSN
Eton Pharmaceuticals Experiences Record Revenue Growth and Analysts See Significant Upside Potential - AInvest
Eton targets $80M revenue run-rate in Q3 2025 as product launches accelerate - MSN
Tools to monitor Eton Pharmaceuticals Inc. recovery probabilityWeekly Breakout Forecast with Entry Zones - Newser
Is Eton Pharmaceuticals Inc. stock reversal real or fakeTrade Safety Matrix for Conservative Traders - Newser
Eton (ETON) Q2 Revenue Jumps 108% - AOL.com
Wall Street Zen Downgrades Eton Pharmaceuticals (NASDAQ:ETON) to Hold - Defense World
Published on: 2025-08-08 22:55:40 - Newser
Eton Pharmaceuticals 2025 Q2 Earnings Narrowed Losses and Strong Revenue Growth - AInvest
2.37%
0.37%
大文字化:
|
ボリューム (24 時間):